financetom
Business
financetom
/
Business
/
EXCLUSIVE: Nano Nuclear Responds To Hunterbrook Short Report, Denounces 'Ulterior Motives,' Affirms Future Timelines (UPDATED)
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EXCLUSIVE: Nano Nuclear Responds To Hunterbrook Short Report, Denounces 'Ulterior Motives,' Affirms Future Timelines (UPDATED)
Jul 26, 2024 1:10 PM

Editor’s note: This story has been updated with additional details from Hunterbrook Media regarding a request for comment to Nano Nuclear ahead of the publication of its short report.

Executives at Nano Nuclear Energy Inc ( NNE ) responded to allegations made in a July short report that sent its share price spiraling downward.

Hunterbrook Allegations: Hunterbrook, a hedge fund that doubles as an investigative news outlet, published a report ridiculing the company on July 19.

The report accused Nano Nuclear, a portable nuclear reactor company in its research stage, of having “no revenue, no products, ‘laughable timelines,’ [and] part-time executives.” Hunterbrook’s article said that the development of nuclear reactors would take much longer than NNE’s timeline.

Nano Responds:  Jay Yu, Founder and Chairman of Nano Nuclear Energy ( NNE ), responded to the allegations made by Hunterbrook in an email to Benzinga.

“We're not sure what we did to deserve any attention from these so-called ‘journalists' who also short sell the stocks that they write about. Since there are clearly ulterior motives none of what is said can be taken seriously, by anyone,” Yu said. “We're proud that NANO is being built at the right place at the right time, contributing to a sustainable energy future.”

James Walker, Chief Executive Officer of Nano Energy, responded to Hunterbrook’s assertion that Nano’s timelines are unrealistic.

"NANO has followed the guidance of the U.S. Nuclear Regulatory Commission (NRC), who currently estimate and advise a 40-month timeline from submission to the issuance of a license for NANO's micronuclear reactors,” Walker said. “This does not even consider potential timing efficiencies stemming from the ADVANCE Act, which was recently signed into law, and which looks to streamline the regulatory process and shorten licensing timeframes.”

“NANO has consulted and is working with NRC veterans with decades of experience and feels comfortable with its development and regulatory timeframes, which are of course subject to risks that we've been very clear to our investors about,” Walker added.

Also Read: Google’s Cookie Monster: Why The Tech Giant’s U-Turn Is Making Waves In Ad Industry

Walker said that the named experts in the report (Allison Macfarlane, a former chair of the FEC, and Paul Dorfman, a visiting fellow at the University of Sussex) are “known to be anti-nuclear and would never say anything good about any nuclear venture.”

Walker went on to say that the authors of the short report “lack education” on nuclear and that microreactors historically took two to three years to license, not 10 to 15 (Hunterbrook reported on an even longer timeline of 15 to 20 years).

The report also claimed that Nano did not respond for comment, which Yu disputed.

“NANO has no missed calls, messages or emails from Hunterbrook through any of our multiple channels. If they did reach out, we would have educated them on all these topics, but they clearly have ulterior motives, which is well documented,” Yu said.

Hunterbrook Media provided Benzinga with two emails it said were sent to Nano Nuclear earlier in July requesting comment.

Yu defended Nano executives’ part-time employment as “sweat equity,” saying that they will be employed full-time when the company is capitalized further.

Yu also referenced Hunterbrook’s short report on Nuscale Power Corp ( SMR ) in June.

“We can all see how that turned out for Hunterbrook,” Yu said. Nuscale shares are trading nearly 30% higher since Hunterbrook’s report.

Price Action: Nano Nuclear went public in May, rising over 500% to a market capitalization of over $600 million.

Its share price declined over 10% after Hunterbrook released its report on July 19 before rebounding later in the day and closing near its open.

NNE was down 3.01% to $15.27 on Tuesday, falling nearly 20% through the first two days of the week. It is still trading more than three times higher than it did during its IPO, though down from its peak of $37.51.

Also Read:

Tech Giants Eye Nuclear Power To Fuel AI Boom, Raising Concerns Over Stability And Environmental Impact: Report

Image created using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Renault, Geely create joint venture for hybrid, combustion engines
Renault, Geely create joint venture for hybrid, combustion engines
May 30, 2024
(Reuters) -French automaker Renault and Chinese partner Geely announced a highly anticipated joint venture on Friday that will develop combustion and hybrid engines, aiming to improve the competitiveness of their legacy auto business. The 50-50 venture is a core element of Renault's strategy to stay in the race against larger competitors by signing multiple partnerships to reduce costs and access...
Employees at some businesses in Russia's Tatarstan region have been evacuated, says state media
Employees at some businesses in Russia's Tatarstan region have been evacuated, says state media
May 30, 2024
May 31 (Reuters) - Employees at several businesses in Russia's Tatarstan region and its administrative centre of Kazan have been evacuated for safety reasons, Russian state news agencies reported on Friday, citing local officials. Airports in the cities of Kazan and Nizhnekamsk in the same region have also imposed temporary flight restrictions for safety reasons, a representative for Rosaviatsia, the...
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
May 30, 2024
May 31 (Reuters) - French drugmaker Sanofi and its partner Regeneron said on Friday the U.S. Food and Drug Administration (FDA) requested additional analyses on the efficacy of Dupixent as an add-on treatment in certain patients 'smoker's lung', or COPD. As a result, the deadline for the review was pushed back by three months, to September 27. Sanofi last year...
Indonesia to issue copper export permits for Freeport, Amman, official says
Indonesia to issue copper export permits for Freeport, Amman, official says
May 30, 2024
JAKARTA, May 31 (Reuters) - Indonesia will issue copper concentrate export permits for miner Freeport Indonesia and Amman Mineral Internasional, a trade ministry official said on Friday, ensuring that exports by both companies would not be disrupted. Freeport's and Amman's current export permits expire on Friday. The permits will take effect from June 1, Budi Santoso, the trade ministry's director...
Copyright 2023-2025 - www.financetom.com All Rights Reserved